Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Veradigm Inc.
  6. News
  7. Summary
    MDRX   US01988P1084

VERADIGM INC.

(MDRX)
  Report
Delayed Nasdaq  -  04:00:00 2023-01-27 pm EST
17.75 USD   -1.77%
01/11Transcript : Veradigm Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 03:45 PM
CI
01/11Veradigm Approves Share Buyback Plan of Up to $250 Million, Provides Fiscal 2023 Guidance
MT
01/11Veradigm Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Tranche Update on Veradigm Inc.'s Equity Buyback Plan announced on January 24, 2022.

11/03/2022 | 03:03pm EST

From July 1, 2022 to September 30, 2022, the company has repurchased 1,957,000 shares, representing 1.77% for $33.62 million. With this, the company has completed the repurchase of 9,749,000 shares, representing 8.53% for $176.84 million under the buyback announced on January 24, 2022.


ę S&P Capital IQ 2022
All news about VERADIGM INC.
01/11Transcript : Veradigm Inc. Presents at 41st Annual J.P. Morgan Healthcare Con..
CI
01/11Veradigm Approves Share Buyback Plan of Up to $250 Million, Provides Fiscal 2023 Guidan..
MT
01/11Veradigm Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
01/11Tranche Update on Veradigm Inc.'s Equity Buyback Plan announced on January 24, 2022.
CI
01/11Veradigm Inc. announces an Equity Buyback for $250 million worth of its shares.
CI
01/11Veradigm Announces New Share Repurchase Program and Initial Financial Guidance for Fisc..
BU
01/11Veradigm Inc. Provides Earnings Guidance for the Fiscal Year 2023
CI
01/11Veradigm Inc. s Equity Buyback announced on January 24, 2022 has expired.
CI
01/11Veradigm Inc. authorizes a Buyback Plan.
CI
01/10Veradigm Building Momentum Across All Markets
BU
More news
Analyst Recommendations on VERADIGM INC.
More recommendations
Financials (USD)
Sales 2022 615 M - -
Net income 2022 -0,65 M - -
Net Debt 2022 - - -
P/E ratio 2022 -645x
Yield 2022 -
Capitalization 1 939 M 1 939 M -
Capi. / Sales 2022 3,15x
Capi. / Sales 2023 2,96x
Nbr of Employees 8 000
Free-Float 38,1%
Chart VERADIGM INC.
Duration : Period :
Veradigm Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VERADIGM INC.
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 17,75 $
Average target price 21,86 $
Spread / Average Target 23,1%
EPS Revisions
Managers and Directors
Richard J. Poulton Chief Executive Officer & Director
Thomas Langan President
Leah Jones Vice President-Finance & Sales Support
Joseph R. Rostock Chief Technology Officer & SVP-Product Engineering
Tejal Vakharia Chief Compliance Counsel & Senior VP
Sector and Competitors
1st jan.Capi. (M$)
VERADIGM INC.0.62%1 939
VEEVA SYSTEMS INC.6.24%26 693
PRO MEDICUS LIMITED17.81%4 832
EVOLENT HEALTH, INC.11.36%3 116
SECTRA AB (PUBL)3.29%2 869
OMNICELL, INC.10.67%2 569